Advertisement

Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil

  • Djanilson Barbosa SantosEmail author
  • Antonio Clavenna
  • Maurizio Bonati
  • Helena Lutescia Luna Coelho
Pharmacoepidemiology and Prescription

Abstract

Objectives

To investigate the use of drugs, the extent and pattern of unlicensed and off-label use, and the potential relationship between off-label drug use and adverse drug reactions in northeastern Brazil.

Methods

A follow-up study of drug utilization in a general ward of a pediatric reference hospital, involving patients hospitalized for more than 24 h. Prescriptions and medical records were reviewed daily from August to December 2001. Drug licensing status of all prescriptions given to these patients was determined.

Results

A total of 272 patients were admitted during the study, 265 (97.4%) of whom received one or more drugs. The median number of drugs/patient was 6 (1–18), and the most frequent diagnosis was pneumonia (29.4% of patients). The therapeutic class most prescribed was anti-infectives for systemic use (68.8% of all children). In all, 82.6% of children received at least one unlicensed or off-label drug, and 17% received both an unlicensed and an off-label drug. Dose/frequency was the most common form of off-label drug use. Off-label drug use was significantly associated with adverse drug reactions (relative risk 2.44; 95% CI 2.12, 2.89).

Conclusions

Although off-label drug use is a complex issue and is not synonymous with inappropriate drug use, a high rate of unlicensed/off-label drug use was found and was also associated with an increased risk of adverse drug reactions. More efforts are needed to increase rational drug use in children.

Keywords

Pharmacoepidemiology Drug utilization Hospitalized children Off-label Unlicensed Pediatrics 

References

  1. 1.
    Gilman JT, Gal P (1992) Pharmacokinetic and pharmacodynamic data collection in children and neonates. Clin Pharmacokinet 23:1–9PubMedGoogle Scholar
  2. 2.
    Kauffman RE, Kearns GL (1992) Pharmacokinetic studies in pediatric patients. Clin Pharmacokinet 23:10–29PubMedCrossRefGoogle Scholar
  3. 3.
    Koren G, Macleod SM (1989) The state of pediatric clinical pharmacology: an international survey of training programs. Clin Pharmacol Ther 5:489–493Google Scholar
  4. 4.
    Sinkowitz RL, Keyserling H, Walker TJ, Holland J et al (1997) Epidemiology of vancomycin usage at a children’s hospital, 1993 through 1995. Pediatr Infect Dis J 16:485–489PubMedCrossRefGoogle Scholar
  5. 5.
    Soumerai SB, Degnan DR (1990) Drug prescribing in pediatrics: challenges for quality improvement. Pediatrics 86:782–784PubMedGoogle Scholar
  6. 6.
    Bonati M, Impicciatore P, Pandolfini C (2000) Registering clinical trials. Register of clinical trials in children must be set up. BMJ 320:1339–1340PubMedCrossRefGoogle Scholar
  7. 7.
    Conroy S, Choonara I, Impicciatore P, Mohn A et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320:79–82PubMedCrossRefGoogle Scholar
  8. 8.
    Santos DB, Coelho HLL (2006) Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf 15:635–640PubMedCrossRefGoogle Scholar
  9. 9.
    Shankar PR, Upadhyay DK, Subish P, Dubey AK et al (2006) Prescribing patterns among paediatric inpatients in a teaching hospital in western Nepal. Singapore Med J 47:261–265PubMedGoogle Scholar
  10. 10.
    Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–555PubMedCrossRefGoogle Scholar
  11. 11.
    Gonzalez MG, Caroca CM, Paris E (1998) Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharmacol Ther 36:530–533Google Scholar
  12. 12.
    Martinez-Mir I, Garcia-Lopez M, Palop V (1999) A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 47:681–688PubMedCrossRefGoogle Scholar
  13. 13.
    Turner S, Nunn T, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 88:965–968PubMedCrossRefGoogle Scholar
  14. 14.
    Mitchell AA, Goldman P, Shapiro S (1979) Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 110:196–204PubMedGoogle Scholar
  15. 15.
    Meiners MMMA, Bergsten-Mendes G (2001) Prescrição de medicamentos para crianças hospitalizadas: como avaliar a qualidade? Rev Assoc Med Bras 47:332–337PubMedCrossRefGoogle Scholar
  16. 16.
    Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J et al (2003) Identificação de medicamentos “não apropriados para crianças” em prescrições de unidades de tratamento intensivo pediátrica. J Pediatr 79:397–402Google Scholar
  17. 17.
    Desta Z, Abula T, Gebre-Yohannes A, Worku A (2002) Drug prescribing patterns for outpatients in three hospitals in north-west Ethiopia. Ethiop J Health Dev 16:183–189Google Scholar
  18. 18.
    Dizwani AG, Stein CCC, Todd WT (1985) Morbidity patterns and prescribing habits in Harare primary care clinics. Farm Pract 2:82–85CrossRefGoogle Scholar
  19. 19.
    da Cunha AJ, Amaral J, Silva MA (2003) Inappropriate antibiotic prescription to children with acute respiratory infection in Brazil. Indian Pediatr 40:7–12PubMedGoogle Scholar
  20. 20.
    Marlière GL, Ferraz MB, dos Santos JQ (2000) Antibiotic consumption patterns and drug leftovers in 6000 Brazilian households. Adv Ther 17:32–44PubMedCrossRefGoogle Scholar
  21. 21.
    Zhanf L, Mendoza R, Costa MM, Ottoni EJ et al (2005) Antibiotic use in community-based pediatric outpatients in southern region of Brazil. J Trop Pediatr 51:304–309CrossRefGoogle Scholar
  22. 22.
    Aseffa A, Yohannes G (1996) Antibiotic sensitivity patterns of prevalent bacterial pathogens in Gondar, Ethiopia. East Afr Med J 73:69–73Google Scholar
  23. 23.
    Wallerstein RD, Gondt PK, Kasper CK (1969) State wide study of chloramphenicol and aplastic anemia. JAMA 208:2045PubMedCrossRefGoogle Scholar
  24. 24.
    Leka T, Abadir M (1990) Prescribing pattern of analgesic drugs in 13 rural and regional hospitals of Ethiopia. Ethiop J Health Dev 4:15–30Google Scholar
  25. 25.
    Bäckström M, Hägg S, Mjörndal T, Dahlqvist R (2002) Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiol Drug Saf 11:239–45PubMedCrossRefGoogle Scholar
  26. 26.
    Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58:265–74PubMedCrossRefGoogle Scholar
  27. 27.
    International Agranulocytosis and Aplastic Anemia Study (1986) Risk of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749–1757CrossRefGoogle Scholar
  28. 28.
    Mulla H, Tofeig M, Bu‘Lock F, Samani N et al (2007) Variations in captopril formulations used to treat children with heart failure: a survey in the United Kingdom. Arch Dis Child 92:409–411PubMedCrossRefGoogle Scholar
  29. 29.
    Conroy S (2003) Extemporaneous (magistral) preparations of oral medicines for children in European hospitals. Acta Paediatr 92:408–410PubMedGoogle Scholar
  30. 30.
    Nascimento-Carvalho CM, Souza-Marques HH (2004) Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Rev Panam Salud Publica 15:380–387PubMedCrossRefGoogle Scholar
  31. 31.
    Agência Nacional de Vigilância Sanitária, Ministério da Saúde, Brazil (2005) Bulário. http://bulario.bvs.br Accessed 2 July 2008
  32. 32.
    Martin J (2007) BNF for children. BMJ, LondonGoogle Scholar
  33. 33.
    Takemoto CK, Hodding JH, Kraus DM (2002) Pediatric dosage handbook. Lexi-Comp, Hudson, OHGoogle Scholar
  34. 34.
    World Health Organization (2007) WHO model list of essential medicines for children. First List, October 2007 http://www.who.int/childmedicines/publications/EMLc%20(2).pdf. Accessed 2 July 2008
  35. 35.
    Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, Tolsa JF, Fanconi S, Pannatier A (2006) Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly 136:218–22PubMedGoogle Scholar
  36. 36.
    ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJ et al (2001) A survey of the use of off-label and unlicensed drugs in a Dutch children’s hospital. Pediatrics 108:1089–1093PubMedCrossRefGoogle Scholar
  37. 37.
    Craig JS, Henderson CR, Magee FA (2001) The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland. Ir Med J 94:237–240PubMedGoogle Scholar
  38. 38.
    Pandolfini C, Impicciatore P, Provasi D, Rocchi F et al (2002) Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 91:339–347PubMedCrossRefGoogle Scholar
  39. 39.
    Turner S, Longworth A, Nunn T, Choonara I (1998) Unlicensed and off-label drug use in paediatric wards: prospective study. BMJ 316:343–345PubMedGoogle Scholar
  40. 40.
    Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, ‘t Jong G, de Hoog M, van den Anker JN (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J 320:79–82CrossRefGoogle Scholar
  41. 41.
    Gavrilov V, Lifshitz M, Levy J, Gorodischer R (2000) Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2:595–597PubMedGoogle Scholar
  42. 42.
    Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54:665–670PubMedCrossRefGoogle Scholar
  43. 43.
    Impicciatore P, Mohn A, Chiarelli F, Pandolfini C, Bonati M (2002) Adverse drug reactions to off-label drugs on a paediatric ward: an Italian prospective pilot study. Paediatr Perinat Drug Ther 5:19–24CrossRefGoogle Scholar
  44. 44.
    Neubert A, Dormann H, Weiss J et al (2004) The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27:1059–1067PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Djanilson Barbosa Santos
    • 1
    • 4
    Email author
  • Antonio Clavenna
    • 3
  • Maurizio Bonati
    • 3
  • Helena Lutescia Luna Coelho
    • 2
  1. 1.Epidemiology and Public Health, Multidisciplinary Institute of HealthFederal University of BahiaVitória da ConquistaBrazil
  2. 2.Department of PharmacyFederal University of CearaFortalezaBrazil
  3. 3.Laboratory for Mother and Child HealthMario Negri Institute of Pharmacological ResearchMilanItaly
  4. 4.Epidemiology and Public HealthFederal University of BahiaFeira de SantanaBrazil

Personalised recommendations